The Journal of thoracic and cardiovascular surgery
The most recent articles from:
J. Thorac. Cardiovasc. Surg.
-
J. Thorac. Cardiovasc. Surg. · Dec 2024
Multicenter Study Observational StudyLow-Dose Warfarin with a Novel Mechanical Aortic Valve: Interim Registry Results at 5-Year Follow-Up.
To evaluate whether warfarin targeted at an international normalized ratio of 1.8 (range, 1.5-2.0) after On-X mechanical aortic valve implant is safe for all patients. ⋯ Interim results support the continued safety of the On-X aortic mechanical valve with a target international normalized ratio of 1.8 plus low-dose aspirin through 5 years after implant, with or without home monitoring.